Literature DB >> 33849467

Implementation of a first-trimester prognostic model to improve screening for gestational diabetes mellitus.

Fieke van Hoorn1, Maria P H Koster2, Anneke Kwee1, Floris Groenendaal3, Arie Franx1,2, Mireille N Bekker4.   

Abstract

BACKGROUND: Improvement in the accuracy of identifying women who are at risk to develop gestational diabetes mellitus (GDM) is warranted, since timely diagnosis and treatment improves the outcomes of this common pregnancy disorder. Although prognostic models for GDM are externally validated and outperform current risk factor based selective approaches, there is little known about the impact of such models in day-to-day obstetric care.
METHODS: A prognostic model was implemented as a directive clinical prediction rule, classifying women as low- or high-risk for GDM, with subsequent distinctive care pathways including selective midpregnancy testing for GDM in high-risk women in a prospective multicenter birth cohort comprising 1073 pregnant women without pre-existing diabetes and 60 obstetric healthcare professionals included in nine independent midwifery practices and three hospitals in the Netherlands (effectiveness-implementation hybrid type 2 study). Model performance (c-statistic) and implementation outcomes (acceptability, adoption, appropriateness, feasibility, fidelity, penetration, sustainability) were evaluated after 6 months by indicators and implementation instruments (NoMAD; MIDI).
RESULTS: The adherence to the prognostic model (c-statistic 0.85 (95%CI 0.81-0.90)) was 95% (n = 1021). Healthcare professionals scored 3.7 (IQR 3.3-4.0) on implementation instruments on a 5-point Likert scale. Important facilitators were knowledge, willingness and confidence to use the model, client cooperation and opportunities for reconfiguration. Identified barriers mostly related to operational and organizational issues. Regardless of risk-status, pregnant women appreciated first-trimester information on GDM risk-status and lifestyle advice to achieve risk reduction, respectively 89% (n = 556) and 90% (n = 564)).
CONCLUSIONS: The prognostic model was successfully implemented and well received by healthcare professionals and pregnant women. Prognostic models should be recommended for adoption in guidelines.

Entities:  

Keywords:  Clinical prediction rule; Gestational diabetes mellitus; Impact analysis; Implementation; MIDI; NoMAD; Normalization process theory; Prognostic model; Risk communication; Selective screening

Year:  2021        PMID: 33849467     DOI: 10.1186/s12884-021-03749-x

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  28 in total

1.  Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention.

Authors:  Helena J Teede; Cheryce L Harrison; Wan T Teh; Eldho Paul; Carolyn A Allan
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-09-23       Impact factor: 2.100

Review 2.  Short- and long-term consequences for offspring exposed to maternal diabetes: a review.

Authors:  S Burlina; M G Dalfrà; A Lapolla
Journal:  J Matern Fetal Neonatal Med       Date:  2017-10-16

3.  Prevalence of gestational diabetes mellitus in Europe: A meta-analysis.

Authors:  Claire E Eades; Dawn M Cameron; Josie M M Evans
Journal:  Diabetes Res Clin Pract       Date:  2017-05-09       Impact factor: 5.602

4.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

Review 5.  Hyperglycemia in pregnancy and its implications for a woman's future risk of cardiovascular disease.

Authors:  Ravi Retnakaran
Journal:  Diabetes Res Clin Pract       Date:  2018-04-19       Impact factor: 5.602

Review 6.  Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes.

Authors:  Luciana Verçoza Viana; Jorge Luiz Gross; Mirela Jobim Azevedo
Journal:  Diabetes Care       Date:  2014-12       Impact factor: 19.112

7.  A multicenter, randomized trial of treatment for mild gestational diabetes.

Authors:  Mark B Landon; Catherine Y Spong; Elizabeth Thom; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Kristine Y Lain; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland B Anderson
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

Review 8.  Prognostic models in obstetrics: available, but far from applicable.

Authors:  C Emily Kleinrouweler; Fiona M Cheong-See; Gary S Collins; Anneke Kwee; Shakila Thangaratinam; Khalid S Khan; Ben Willem J Mol; Eva Pajkrt; Karel G M Moons; Ewoud Schuit
Journal:  Am J Obstet Gynecol       Date:  2015-06-10       Impact factor: 8.661

9.  A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.

Authors:  Byron J Powell; Thomas J Waltz; Matthew J Chinman; Laura J Damschroder; Jeffrey L Smith; Monica M Matthieu; Enola K Proctor; JoAnn E Kirchner
Journal:  Implement Sci       Date:  2015-02-12       Impact factor: 7.327

10.  Development of a theory of implementation and integration: Normalization Process Theory.

Authors:  Carl R May; Frances Mair; Tracy Finch; Anne MacFarlane; Christopher Dowrick; Shaun Treweek; Tim Rapley; Luciana Ballini; Bie Nio Ong; Anne Rogers; Elizabeth Murray; Glyn Elwyn; France Légaré; Jane Gunn; Victor M Montori
Journal:  Implement Sci       Date:  2009-05-21       Impact factor: 7.327

View more
  1 in total

Review 1.  Optimising Cardiometabolic Risk Factors in Pregnancy: A Review of Risk Prediction Models Targeting Gestational Diabetes and Hypertensive Disorders.

Authors:  Eleanor P Thong; Drishti P Ghelani; Pamada Manoleehakul; Anika Yesmin; Kaylee Slater; Rachael Taylor; Clare Collins; Melinda Hutchesson; Siew S Lim; Helena J Teede; Cheryce L Harrison; Lisa Moran; Joanne Enticott
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.